Metlife
At a glance
Metlife reported 2025 revenue of $2.44B, up 8.5% from $2.25B in 2024. Over 4 years since 2021 ($2.07B), that is growth of about 4.1% a year. Operating margin was 251.9%. 2025 was the highest revenue year in this period.
In the last 12 months 1 insider reported 0 open-market purchases and 1 sale ($1.7M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $1.7M by EVP & Chief Risk Officer Marlene Debel on Jun 3, 2026.
Metlife filed 19 current reports (Form 8-K) in the last 12 months, most often for regulation fd disclosure (7), other events (6), results of operations (4) and shareholder vote results (1). The latest officer or director change was reported on Feb 24, 2026.
2 of the 20 investors tracked here held Metlife at the last quarter end, worth $160.8M combined. It is the largest weight for Bridgewater Associates (0.2% of its portfolio), followed by National Pension Service (Korea) (0.1%). Added: National Pension Service (Korea).
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $6.35B | $2.35B | $1.38B | $4.23B | $3.17B |
| Diluted EPS | $7.65 | $6.30 | $1.81 | $5.94 | $4.71 |
| Dividend per share | $1.90 | $1.98 | $2.06 | $2.15 | $2.25 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined